Pirtobrutinib in richter transformation: Updated efficacy and safety results with 18-month median survival follow-up from the phase 1/2 BRUIN study Meeting Abstract
| Authors: | Wierda, W. G.; Shah, N. N.; Cheah, C. Y.; Lewis, D.; Hoffmann, M. S.; Coombs, C. C.; Lamanna, N.; Ma, S.; Jagadeesh, D.; Munir, T.; Wang, Y.; Eyre, T. A.; Rhodes, J. M.; McKinney, M.; Lech-Maranda, E.; Tam, C. S.; Jurczak, W.; Izutsu, K.; Alencar, A. J.; Patel, M.; Seymour, J. F.; Woyach, J. A.; Roeker, L. E.; Thompson, P. A.; Abada, P.; Ho, C.; Marella, N.; Wang, C.; Ruppert, A. S.; Nair, B. C.; Liu, H.; Tsai, D. E.; Ghia, P. |
| Abstract Title: | Pirtobrutinib in richter transformation: Updated efficacy and safety results with 18-month median survival follow-up from the phase 1/2 BRUIN study |
| Meeting Title: | 65th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 142 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Dec 9-12 |
| Meeting Location: | San Deigo, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2023-11-02 |
| Start Page: | 1737 |
| Language: | English |
| ACCESSION: | WOS:001159306706208 |
| DOI: | 10.1182/blood-2023-181108 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
